Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Prospective Longitudinal Study on Immunogenicity, Induction of Cellular Immune Responses and Safety of Vaccination Against HPV With the 9-valent Vaccine in HIV-positive Women (The Papillon Study)

NCT03391921 is registered in ClinicalTrials.gov with Centre Hospitalier Universitaire Saint Pierre as lead sponsor.

NCT NCT03391921
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03391921 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Prospective Longitudinal Study on Immunogenicity, Induction of Cellular Immune Responses and Safety of Vaccination Against HPV With the 9-valent Vaccine in HIV-positive Women (The Papillon Study)
Lead sponsor
Centre Hospitalier Universitaire Saint Pierre
Phase
Phase 4
Overall status
Active, not recruiting
Start date
January 8, 2018
Completion date
May 2, 2028
Enrollment
170 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

hiv infections, hpv - anogenital human papilloma virus infection